Hi good1234,I agree with most of your angst. However with...

Hi good1234,

I agree with most of your angst. However with regards to the European Trial I'm hopeful what Anteotech has detailed in the Quarterly Business Update ending 30 June 22 materialises. Specifically page 9 of 11 -

Covid-19 RAT

Point 2. Submission EU Common List Registration – AnteoTech anticipates submitting for European
Common List registration in Q4 CY2022. The submission's timing depends on the clinical trial
progress and receipt of an Interim Analysis of the European clinical trial. The Interim Analysis
can only be used for submission purposes and will not be made public so as not to breach the
trial requirements before it has been closed out.

I'm disappointed with the company's trials in Australia, India, UK etc. over the last 18 months not resulting in registration with the various regulatory body/ies sought . But I have no reason to believe that the trials underway in Europe won't result in Submission of EU Common List Registration. When or if the Test is registered will rely on the various regulatory body/ies circa by Q1 CY2023.

Let's hope the Postman delivers!